RT Journal Article
SR Electronic
T1 Workplace measures against COVID-19 during the winter third wave in Japan: company size-based differences
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.14.21251716
DO 10.1101/2021.02.14.21251716
A1 Ishimaru, Tomohiro
A1 Nagata, Masako
A1 Hino, Ayako
A1 Yamashita, Satoshi
A1 Tateishi, Seiichiro
A1 Tsuji, Mayumi
A1 Ogami, Akira
A1 Matsuda, Shinya
A1 Fujino, Yoshihisa
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/02/16/2021.02.14.21251716.abstract
AB Objectives Little is known about workplace measures against coronavirus disease 2019 (COVID-19) in Japan after the first state of emergency period, especially in micro-, small-, and medium-sized enterprises (MSMEs). This study aimed to provide an overview of the current situation of anti-COVID-19 measures in Japanese enterprises, considering company size.Methods This study was an Internet-based nationwide cross-sectional study. Data were collected using an online self-administered questionnaire in December 2020 during the third wave of COVID-19. The chi-squared test for trend was performed to calculate the p-value for trend for each workplace measure across company sizes.Results For the 27,036 participants, across company sizes, the most prevalent workplace measure was encouraging mask wearing at work, followed by requesting that employees refrain from going to work when ill and restricting work-related social gatherings and entertainment. These measures were implemented by approximately 90% of large-scale enterprises and by more than 40% of micro- and small-scale enterprises. In contrast, encouraging remote working and restricting eating and drinking at personal workspaces were implemented by less than half of large-scale enterprises and by around 15% of micro- and small-scale enterprises. There were statistically significant differences in all workplace measures by company size (all p-values < .001).Conclusions We found that various responses to COVID-19 had been taken in workplaces. However, some measures, including remote working, were still not well implemented, especially in smaller enterprises. The findings suggest that occupational health support for MSMEs is urgently needed to mitigate the current wave of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a research fund from the University of Occupational and Environmental Health, Japan; General Incorporated Foundation (Anshin Zaidan): The Development of Educational Materials on Mental Health Measures for Managers at Small-sized Enterprises; Health, Labour and Welfare Sciences Research Grants: Comprehensive Research for Women's Healthcare (H30-josei-ippan-002); Research for the Establishment of an Occupational Health System in Times of Disaster (H30-roudou-ippan-007), and scholarship donations from CHUGAI PHARMACEUTICAL CO., LTD.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the University of Occupational and Environmental Health, Japan.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo additional data are available.